Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Ophthalmology | Family Medicine
Clinical Trials: Ocular Hypertension
A listing of clinical trials currently looking for volunteers to enroll in Ocular Hypertension studies. Click on the closest city to find more detailed information on a research study in your area.
California
Artesia : Kenneth Sall, M.D.
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
Artesia : Artesia Clinical Site - Site 02
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Artesia :
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Costa Mesa : Costa Mesa Clinical Site
Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma
Glendale :
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
View More »
Inglewood : United Medical Research Institute
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
Inglewood : Inglewood Clinical Site - Site 03
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
La Jolla : University of California San Diego
BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Newport Beach : Aesthetic Eye Care Institute
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
Newport Beach : Newport Beach (satellite site)
Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma
Petaluma : North Bay Eye Associates
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
Petaluma : Petaluma Clinical Site - Site 05
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Poway : Centre For Health Care
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
San Francisco : Glaucoma Center of San Francisco
The Efficacy of Selective Laser Trabeculoplasty
Santa Ana : Santa Ana (satellite site)
Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma
Connecticut
New Haven : New Haven Clinical Site - Site 01
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Georgia
Atlanta : Atlanta Clinical Site - Site 04
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Morrow : Clayton Eye Center
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
Morrow :
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
Roswell : Coastal Research Associates, LLC
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
Roswell :
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Kansas
Shawnee Mission : Bradley Kwapiszeski, MD
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
Kentucky
Lexington : Univ of Ky
Safety Study of Latanoprost Slow Release Insert
Lexington : University of Kentucky
Safety Study of Latanoprost Slow Release Insert
Louisville : Taustine Eye Center
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
Louisville :
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Maryland
Baltimore : Alan L Robin, M.D.
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
Havre de Grace : Seidenberg Protzko Eye Associates
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
Michigan
St Joseph : Great Lakes Eye Care
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
New York
Rochester : Rochester Ophthalmological Group
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
Rochester :
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
North Carolina
Charlotte : Charlotte Eye Ear Nose and Throat
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
High Point : Michael E. Tepedino, M.D.
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
High Point :
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
High Point : High Point Clinical Site - Site 06
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
Oklahoma
Tulsa : The Eye Institute
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
Texas
Austin : Texan Eye
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
Austin :
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
El Paso : Cataract & Glaucoma Center
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
Fort Worth : Contact Alcon Call Center for Trial Locations
Efficacy of Changing to Travatan From Prior Therapy
Fort Worth : Contact Alcon Call Center for Trial Locations
Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-angle Glaucoma or Ocular Hypertension
View More »
San Antonio : Medical Center Ophth. Associates
A Phase 2, Double-masked, Randomized, Multi-center, Active-controlled, Dose-response Parallel-group Study Comparing the Safety and Ocular Hypotensive Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
San Antonio :
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Armenia
Yerevan : S.V. Malayan Ophthalmological Center
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost
Australia
Fitzroy :
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
Austria
Vienna :
A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Belgium
Brazil
São Paulo :
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Bulgaria
Sofia :
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
Canada
Mississauga : Ophthalmic Consultants Centres
A Investigator Masked Parallel Comparison of Tolerability of Combigan and Cosopt
Vancouver :
Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction
Vaughan :
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
Colombia
Bogotá :
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Czech Republic
Brno : Fakultni nemocnice Brno
Long-Term Non-Interventional Latanoprost Study
Praha 5 : Fakultni nemocnice v Motole
Long-Term Non-Interventional Latanoprost Study
Zlin :
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
Denmark
Glostrup : Glostrup Hospital, Oegenafdelingen
Long-Term Non-Interventional Latanoprost Study
Estonia
Tallin : East Tallin Central Hospital
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Tallin : Eye Clinic Dr. Krista Turman
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Finland
Kuopio : Eye clinic, University Hospital of Kuopio
Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies
Tampere : FinnMedi Oy, Clinical Trial Center
The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma
France
Amiens : CHU d'Amiens -Centre Saint Victor
Long-Term Non-Interventional Latanoprost Study
Lille Cedex : Hopital Claude Huriez
Long-Term Non-Interventional Latanoprost Study
Lyon :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Germany
Dresden :
A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Freiburg : Universitaetsklinikum Freiburg
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Giessen : Universitaetsklinikum Giessen
Long-Term Non-Interventional Latanoprost Study
Hamburg : Universitaetsklinikum Hamburg-Eppendorf
Long-Term Non-Interventional Latanoprost Study
Köln : Uniklinik Köln
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
View More »
Mainz : Universitaetsklinikum Mainz
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Mainz : Universitaetsklinikum Mainz
Long-Term Non-Interventional Latanoprost Study
Mainz :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Greece
Hungary
Budapest :
A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
India
Gurgaon : MSD Pharmaceuticals Private Ltd.
Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002 AM1)
Israel
Haifa : Bnei Zion Medical Center
Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
Petach Tikva :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Tel Aviv :
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
Italy
Catania : Azienda Ospedaliero Univ.
Long-Term Non-Interventional Latanoprost Study
Fiumicino (Roma) : Ospedale Pediatrico Bambino Gesu
Long-Term Non-Interventional Latanoprost Study
Genova : Istituto Giannina Gaslini, Divisione di Oculistica
Long-Term Non-Interventional Latanoprost Study
Milano : Unita' Operativa di Oculistica Pediatrica, Azienda Ospedaliera Ospedale Niguarda Ca'Grande
Long-Term Non-Interventional Latanoprost Study
Milano :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Japan
Osaka : Santen study sites
DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension
Mexico
Mexico City :
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Netherlands
Amsterdam :
A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Peru
Miraflores : Óptima Visión
Long-Term Non-Interventional Latanoprost Study
Poland
Gdańsk :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Portugal
Slovakia
Spain
Barcelona : Institut Català de Retina
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Esplugues de Llobregat : Hospital Sant Joan de Deu
Long-Term Non-Interventional Latanoprost Study
Madrid : Hospital Universitario 12 de Octubre
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Madrid : Hospital Universitario Ramón y Cajal
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Madrid : Hospital Universitario Clínico San Carlos
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
View More »
Madrid : Hospital Clinico San Carlos
Long-Term Non-Interventional Latanoprost Study
Pamplona : Clinica Universidad Navarra
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Sevilla : Hospital Virgen Del Rocio
Long-Term Non-Interventional Latanoprost Study
Torrevieja :
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Valladolid : Instituto de Oftalmobiología Aplicada
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
Zaragoza : Hospital Universitario Miguel Servet
Long-Term Non-Interventional Latanoprost Study
Sweden
Uppsala : Akademiska Sjukhuset
Long-Term Non-Interventional Latanoprost Study
Vasteras : Ogonkliniken, Centrallasarett
Long-Term Non-Interventional Latanoprost Study
United Kingdom
